Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Spyre Therapeutics Inc.’s stock clocked out at $28.49, down -1.96% from its previous closing price of $29.06. In other words, the price has decreased by -$1.96 from its previous closing price. On the day, 0.65 million shares were traded. SYRE stock price reached its highest trading level at $29.515 during the session, while it also had its lowest trading level at $28.06.
Ratios:
To gain a deeper understanding of SYRE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.70 and its Current Ratio is at 19.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on September 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $45.
On May 02, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $50.Robert W. Baird initiated its Outperform rating on May 02, 2024, with a $50 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 03 ’24 when Burrows Scott L sold 18,531 shares for $28.17 per share. The transaction valued at 522,074 led to the insider holds 116,422 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SYRE now has a Market Capitalization of 1450702208 and an Enterprise Value of 1177134720.
Stock Price History:
Over the past 52 weeks, SYRE has reached a high of $47.97, while it has fallen to a 52-week low of $8.43. The 50-Day Moving Average of the stock is 2.15%, while the 200-Day Moving Average is calculated to be -2.81%.
Shares Statistics:
It appears that SYRE traded 621.08K shares on average per day over the past three months and 880370 shares per day over the past ten days. A total of 50.92M shares are outstanding, with a floating share count of 45.37M. Insiders hold about 10.89% of the company’s shares, while institutions hold 92.39% stake in the company. Shares short for SYRE as of 1726185600 were 8724826 with a Short Ratio of 14.05, compared to 1723680000 on 8042707. Therefore, it implies a Short% of Shares Outstanding of 8724826 and a Short% of Float of 20.26.
